158 related articles for article (PubMed ID: 29618938)
1. Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series.
Bernhardt D; Sterzing F; Adeberg S; Herfarth K; Katayama S; Foerster R; Hoerner-Rieber J; König L; Debus J; Rieken S
Cancer Manag Res; 2018; 10():583-588. PubMed ID: 29618938
[TBL] [Abstract][Full Text] [Related]
2. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck.
Jensen AD; Debus J
Radiat Oncol; 2019 Nov; 14(1):194. PubMed ID: 31694720
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].
Jensen AD; Nikoghosyan A; Hinke A; Debus J; Münter MW
BMC Cancer; 2011 Feb; 11():70. PubMed ID: 21320355
[TBL] [Abstract][Full Text] [Related]
5. Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study.
Lang K; Adeberg S; Harrabi S; Held T; Kieser M; Debus J; Herfarth K
BMC Cancer; 2021 Jul; 21(1):812. PubMed ID: 34266402
[TBL] [Abstract][Full Text] [Related]
6. Treatment Outcome of 227 Patients with Sinonasal Adenoid Cystic Carcinoma (ACC) after Intensity Modulated Radiotherapy and Active Raster-Scanning Carbon Ion Boost: A 10-Year Single-Center Experience.
Akbaba S; Ahmed D; Mock A; Held T; Bahadir S; Lang K; Syed M; Hoerner-Rieber J; Forster T; Federspil P; Herfarth K; Plinkert P; Debus J; Adeberg S
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31683896
[TBL] [Abstract][Full Text] [Related]
7. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
[TBL] [Abstract][Full Text] [Related]
8. Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Chaudhri N; Uhl M; Münter MW; Herfarth KK; Debus J
Radiother Oncol; 2015 Feb; 114(2):182-8. PubMed ID: 25640299
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
10. Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity.
Lang K; Baur M; Akbaba S; Held T; Kargus S; Bougatf N; Bernhardt D; Freier K; Plinkert PK; Rieken S; Debus J; Adeberg S
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30518108
[TBL] [Abstract][Full Text] [Related]
11. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Welzel T; Uhl M; Federspil PA; Freier K; Krauss J; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Radiother Oncol; 2016 Feb; 118(2):272-80. PubMed ID: 26164774
[TBL] [Abstract][Full Text] [Related]
12. Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.
Jensen AD; Nikoghosyan AV; Ecker S; Ellerbrock M; Debus J; Herfarth KK; Münter MW
Radiat Oncol; 2011 Nov; 6():149. PubMed ID: 22046954
[TBL] [Abstract][Full Text] [Related]
13. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J
Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864
[TBL] [Abstract][Full Text] [Related]
14. Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands.
Schmid MP; Held T; Lang K; Herfarth K; Hörner-Rieber J; Harrabi SB; Moratin J; Freudlsperger C; Zaoui K; Debus J; Adeberg S
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401730
[No Abstract] [Full Text] [Related]
15. Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost.
Schulz-Ertner D; Didinger B; Nikoghosyan A; Jäkel O; Zuna I; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 May; 179(5):345-51. PubMed ID: 12740662
[TBL] [Abstract][Full Text] [Related]
16. The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
Adeberg S; Akbaba S; Lang K; Held T; Verma V; Nikoghosyan A; Bernhardt D; Münter M; Freier K; Plinkert P; Hauswald H; Herfarth K; Rieken S; Debus J; Jensen AD
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):167-173. PubMed ID: 31586664
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas.
Schulz-Ertner D; Nikoghosyan A; Jäkel O; Haberer T; Kraft G; Scholz M; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):391-8. PubMed ID: 12738314
[TBL] [Abstract][Full Text] [Related]
18. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.
Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S
Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061
[TBL] [Abstract][Full Text] [Related]
19. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment.
Münter MW; Schulz-Ertner D; Hof H; Nikoghosyan A; Jensen A; Nill S; Huber P; Debus J
Radiat Oncol; 2006 Jun; 1():17. PubMed ID: 16756669
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
